Questionnaire for Uterine Cancer Survivors

LL
Overseen ByLilie L. Lin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand pelvic floor issues and quality of life in uterine cancer survivors. Participants will fill out a questionnaire about health, lifestyle, and the impact of cancer treatments. The study seeks individuals who underwent uterine cancer surgery at MD Anderson between 2006 and 2017 and have been disease-free for at least a year. This information could help improve future care and support for survivors. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance the quality of life for future uterine cancer survivors.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on completing surveys about quality of life and sexual function.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on understanding how pelvic floor dysfunction affects the quality of life in uterine cancer survivors. Unlike traditional treatments that aim to manage the physical symptoms of uterine cancer or its direct side effects, this approach uses detailed questionnaires to gather insights on patients' demographic, treatment history, lifestyle, and comorbidities. Through this method, the trial seeks to illuminate the broader impact of cancer treatment on daily living, offering a chance to identify specific issues that might be overlooked by conventional care. This could lead to more personalized support and interventions to improve survivors' overall well-being.

Who Is on the Research Team?

LL

Lilie L Lin

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

Patients with uterine cancer (including endometrial and uterine carcinoma or sarcoma) treated with surgery +/- radiation at MD Anderson between 2006 and 2017
Eligible surgeries include laparoscopic or robotic assisted abdominal total hysterectomy, total abdominal hysterectomy, and vaginal hysterectomy with or without pelvic node dissection, with or without omentectomy or omental biopsies
In addition, patients must have had all WITH bilateral-salpingo-oophorectomy (BSO), either during their surgery or in a previous or subsequent (within 3 months of endometrial cancer diagnosis) surgery
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational

Participants complete questionnaires over 45-60 minutes assessing quality of life and pelvic floor dysfunction

1 day
1 visit (in-person or virtual)

Follow-up

Participants are monitored for pelvic floor distress and quality of life over time

Up to 1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Questionnaire Administration

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Observational (questionnaires)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+